Literature DB >> 29960019

Nano-diamino-tetrac (NDAT) inhibits PD-L1 expression which is essential for proliferation in oral cancer cells.

Shan-Jen Lin1, Yu-Tang Chin2, Yih Ho3, Szu-Yi Chou4, Yu-Chen Sh Yang5, André Wendindondé Nana6, Kuan-Wei Su1, Yee-Tong Lim7, Kuan Wang8, Sheng-Yang Lee9, Ya-Jung Shih2, Yi-Ru Chen2, Jacqueline Whang-Peng10, Paul J Davis11, Hung-Yun Lin12, Earl Fu13.   

Abstract

Programmed death-ligand 1 (PD-L1) is a critical regulator to defend tumor cells against immune surveillance. Thyroid hormone has been shown to induce PD-L1 expression in cancer cells. Its nano-particulated analogue, nano-diamino-tetrac (NDAT; Nanotetrac) is an anticancer/anti-angiogenic agent. In the current study, the inhibitory mechanism by which NDAT inhibited PD-L1 mRNA abundance and PD-L1 protein content in oral cancer cells was investigated. NDAT inhibited inducible PD-L1 expression and protein accumulation by the inhibition of activated ERK1/2 and PI3K. Knockdown PD-L1 also inhibited the proliferation of oral cancer cells which suggests that the inhibitory effect of NDAT on PD-L1 expression maybe is one of the critical mechanisms for NDAT-induced anti-proliferative effect in oral cancer cells.
Copyright © 2018. Published by Elsevier Ltd.

Entities:  

Keywords:  NDAT; Oral cancer; PD-L1; Proliferation; Thyroxine

Mesh:

Substances:

Year:  2018        PMID: 29960019     DOI: 10.1016/j.fct.2018.06.058

Source DB:  PubMed          Journal:  Food Chem Toxicol        ISSN: 0278-6915            Impact factor:   6.023


  8 in total

1.  Tetrac and NDAT Induce Anti-proliferation via Integrin αvβ3 in Colorectal Cancers With Different K-RAS Status.

Authors:  Yu-Tang Chin; Zong-Rong He; Chi-Long Chen; Hsiao-Ching Chu; Yih Ho; Po-Yu Su; Yu-Chen S H Yang; Kuan Wang; Ya-Jung Shih; Yi-Ru Chen; Jens Z Pedersen; Sandra Incerpi; André Wendindondé Nana; Heng-Yuan Tang; Hung-Yun Lin; Shaker A Mousa; Paul J Davis; Jacqueline Whang-Peng
Journal:  Front Endocrinol (Lausanne)       Date:  2019-03-12       Impact factor: 5.555

Review 2.  Herbal Medicines Attenuate PD-L1 Expression to Induce Anti-Proliferation in Obesity-Related Cancers.

Authors:  Yu-Chen S H Yang; Zi-Lin Li; Ya-Jung Shih; James A Bennett; Jaqueline Whang-Peng; Hung-Yun Lin; Paul J Davis; Kuan Wang
Journal:  Nutrients       Date:  2019-12-05       Impact factor: 5.717

Review 3.  Role of thyroid hormone-integrin αvβ3-signal and therapeutic strategies in colorectal cancers.

Authors:  Yu-Chen S H Yang; Po-Jui Ko; Yi-Shin Pan; Hung-Yun Lin; Jacqueline Whang-Peng; Paul J Davis; Kuan Wang
Journal:  J Biomed Sci       Date:  2021-04-08       Impact factor: 8.410

4.  Effects of Anticancer Agent P-bi-TAT on Gene Expression Link the Integrin Thyroid Hormone Receptor to Expression of Stemness and Energy Metabolism Genes in Cancer Cells.

Authors:  Gennadi V Glinsky; Kavitha Godugu; Thangirala Sudha; Mehdi Rajabi; Sridar V Chittur; Aleck A Hercbergs; Shaker A Mousa; Paul J Davis
Journal:  Metabolites       Date:  2022-04-04

5.  NDAT Targets PI3K-Mediated PD-L1 Upregulation to Reduce Proliferation in Gefitinib-Resistant Colorectal Cancer.

Authors:  Tung-Yung Huang; Tung-Cheng Chang; Yu-Tang Chin; Yi-Shin Pan; Wong-Jin Chang; Feng-Cheng Liu; Ema Dwi Hastuti; Shih-Jiuan Chiu; Shwu-Huey Wang; Chun A Changou; Zi-Lin Li; Yi-Ru Chen; Hung-Ru Chu; Ya-Jung Shih; R Holland Cheng; Alexander Wu; Hung-Yun Lin; Kuan Wang; Jacqueline Whang-Peng; Shaker A Mousa; Paul J Davis
Journal:  Cells       Date:  2020-08-03       Impact factor: 6.600

6.  In tumor cells, thyroid hormone analogues non-immunologically regulate PD-L1 and PD-1 accumulation that is anti-apoptotic.

Authors:  Hung-Yun Lin; Yu-Tang Chin; Ya-Jung Shih; Yi-Ru Chen; Matthew Leinung; Kelly A Keating; Shaker A Mousa; Paul J Davis
Journal:  Oncotarget       Date:  2018-09-25

7.  Resveratrol antagonizes thyroid hormone-induced expression of checkpoint and proliferative genes in oral cancer cells.

Authors:  Chia-Cheng Lin; Yu-Tang Chin; Ya-Jung Shih; Yi-Ru Chen; Yao-Yu Chung; Chi-Yu Lin; Chao-Nan Hsiung; Jacqueline Whang-Peng; Sheng-Yang Lee; Hung-Yun Lin; Paul J Davis; Kuan Wang
Journal:  J Dent Sci       Date:  2019-03-27       Impact factor: 2.080

Review 8.  Insights into Nanomedicine for Immunotherapeutics in Squamous Cell Carcinoma of the head and neck.

Authors:  Qiang Xu; Meiyu Fang; Jing Zhu; Haoru Dong; Jun Cao; Lin Yan; Fransisca Leonard; Felix Oppel; Holger Sudhoff; Andreas M Kaufmann; Andreas E Albers; Xu Qian
Journal:  Int J Biol Sci       Date:  2020-07-19       Impact factor: 6.580

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.